1468-1331/asset/olbannerleft.jpg?v=1&s=5d3a3e0b13870c31eb751e2f9ac484568b81fd0e)
The effect of magnesium oral therapy on spasticity in a patient with multiple sclerosis
Article first published online: 4 JAN 2002
DOI: 10.1046/j.1468-1331.2000.00142.x
1468-1331/asset/cover.gif?v=1&s=02086c94ae38501b239f31e52894de795d835902 "European Journal of Neurology")
Additional Information
How to Cite
Rossier, P., van Erven, S. and Wade, D. T. (2000), The effect of magnesium oral therapy on spasticity in a patient with multiple sclerosis. European Journal of Neurology, 7: 741–744. doi: 10.1046/j.1468-1331.2000.00142.x
Publication History
- Issue published online: 4 JAN 2002
- Article first published online: 4 JAN 2002
- Received 10 February 2000Accepted 9 June 2000
- Abstract
- Article
- References
- Cited By
Keywords:
- magnesium;
- multiple sclerosis;
- muscle relaxation;
- spasticity
The effects of magnesium glycerophosphate oral therapy on spasticity was studied in a 35-year-old woman with severe spastic paraplegia resulting from multiple sclerosis (MS). We found a significant improvement in the spasticity after only 1 week from the onset of the treatment on the modified Ashworth scale, an improvement in the range of motion and in the measures of angles at resting position in lower limbs. No side-effects were reported and there was no weakness in the arms during the treatment.